TNF-α and IL-6: The Link between Immune and Bone System

被引:268
作者
Wang, Tiantian [1 ,2 ]
He, Chengqi [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Rehabil Med, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Key Lab Rehabil Med, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
TNF-alpha; IL-6; osteoimmunology; osteoclast; osteoblast; osteocyte; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; MESENCHYMAL STEM-CELLS; NATURAL-KILLER-CELLS; RHEUMATOID-ARTHRITIS PATIENTS; LEUKEMIA INHIBITORY FACTOR; HUMAN OSTEOCLAST FORMATION; COLONY-STIMULATING FACTOR; T-CELLS; OSTEOBLAST DIFFERENTIATION;
D O I
10.2174/1389450120666190821161259
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Osteoimmunology is a new subject which focuses on the communication between the immune and the skeletal systems. Both the immune system and bone communicate with each other. Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) play important roles in immune responses and bone metabolism. TNF-alpha and IL-6 enhance macrophage activation and antigen presentation, as well as regulating immunity through different mechanisms. A variety of groups have reported that TNF-alpha suppresses osteoblasts activity at some stages of differentiation and stimulates osteoclast proliferation and differentiation. In contrast, IL-6 mediates the actions of osteoblasts and osteoclasts through sophisticated mechanisms, which reflect dual effects. Both TNF-alpha and IL-6 can mediate the activity of osteocytes. Furthermore, both TNF-alpha and IL-6 are important pathogenic factors related to immune-mediated bone diseases including rheumatoid arthritis and postmenopausal osteoporosis. This review will discuss the contradictory findings concerning TNF-alpha and IL-6 in osteoimmunology and their potential for clinical application.
引用
收藏
页码:213 / 227
页数:15
相关论文
共 196 条
  • [1] Tumor necrosis factor-α inhibits pre-osteoblast differentiation through its type-1 receptor
    Abbas, S
    Zhang, YH
    Clohisy, JC
    Abu-Amer, Y
    [J]. CYTOKINE, 2003, 22 (1-2) : 33 - 41
  • [2] Immune regulation of bone loss by Th17 cells
    Adamopoulos, Iannis E.
    Bowman, Edward P.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2008, 10 (05)
  • [3] Chemokines and tuberculosis
    Algood, HMS
    Chan, J
    Flynn, JL
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (06) : 467 - 477
  • [4] Regulation of Osteoclast Differentiation by Cytokine Networks
    Amarasekara, Dulshara Sachini
    Yun, Hyeongseok
    Kim, Sumi
    Lee, Nari
    Kim, Hyunjong
    Rho, Jaerang
    [J]. IMMUNE NETWORK, 2018, 18 (01)
  • [5] Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
    Ammann, P
    Rizzoli, R
    Bonjour, JP
    Bourrin, S
    Meyer, JM
    Vassalli, P
    Garcia, I
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) : 1699 - 1703
  • [6] Angelotti F, 2017, CLIN EXP RHEUMATOL, V35, P368
  • [7] Regulation of hematopoietic stem cells by bone marrow stromal cells
    Anthony, Bryan A.
    Link, Daniel C.
    [J]. TRENDS IN IMMUNOLOGY, 2014, 35 (01) : 32 - 37
  • [8] Osteoimmunology - Bone versus immune system
    Arron, JR
    Choi, Y
    [J]. NATURE, 2000, 408 (6812) : 535 - 536
  • [9] Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts
    Azuma, Y
    Kaji, K
    Katogi, R
    Takeshita, S
    Kudo, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) : 4858 - 4864
  • [10] IL-6 Alters Osteocyte Signaling toward Osteoblasts but Not Osteoclasts
    Bakker, A. D.
    Kulkarni, R. N.
    Klein-Nulend, J.
    Lems, W. F.
    [J]. JOURNAL OF DENTAL RESEARCH, 2014, 93 (04) : 394 - 399